Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | ZTS | TAK | NBIX | UTHR |
| Company | Recursion Pharmaceuticals Inc Cl A | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 9.24 | 170.45 | 13.34 | 140.90 | 260.33 |
| High | 9.40 | 171.69 | 13.41 | 141.88 | 262.51 |
| Low | 8.70 | 166.95 | 13.30 | 139.23 | 255.93 |
| Last | 8.84 | 167.07 | 13.37 | 140.71 | 262.40 |
| Change | +0.05 | -0.16 | +0.10 | +0.88 | +4.27 |
| % Change | +0.57% | -0.10% | +0.75% | +0.63% | +1.65% |
| Volume | 3,981,000 | 3,007,107 | 1,333,986 | 616,500 | 779,500 |
| 20-Day Average Volume | 4,101,880 | 4,574,175 | 1,625,240 | 803,360 | 557,520 |
| Previous Close | 8.79 | 167.23 | 13.27 | 139.83 | 258.13 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.14 | 156.63 | 13.30 | 136.80 | 239.11 |
| 20-Day Raw Stochastic | 75.28% | 82.82% | 47.40% | 70.11% | 99.66% |
| 20-Day Relative Strength | 48.72% | 52.97% | 44.05% | 54.80% | 67.92% |
| Weighted Alpha | -26.61 | -11.45 | -20.15 | +45.16 | +26.59 |
| Today's Opinion | 40% Sell | 56% Sell | 88% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 40% Sell | 64% Sell | 100% Sell | 88% Buy | 88% Buy |
| Last Month's Opinion | 8% Sell | 56% Sell | 88% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.87% since 04/26/24 | +5.46% since 04/26/24 | +2.61% since 04/26/24 | +3.47% since 04/26/24 | +12.21% since 04/26/24 |
| Low | 7.73 on 05/01/24 | 158.04 on 05/01/24 | 13.08 on 05/01/24 | 136.01 on 05/01/24 | 233.31 on 04/30/24 |
| High | 9.40 on 05/03/24 | 171.69 on 05/03/24 | 13.41 on 05/03/24 | 145.22 on 05/01/24 | 262.51 on 05/03/24 |
| 1-Month | |||||
| %Chg | -1.01% since 04/03/24 | +2.52% since 04/03/24 | -1.18% since 04/03/24 | +2.27% since 04/03/24 | +13.49% since 04/03/24 |
| Low | 7.14 on 04/19/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 229.72 on 04/04/24 |
| High | 9.40 on 05/03/24 | 171.69 on 05/03/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 262.51 on 05/03/24 |
| 3-Month | |||||
| %Chg | -4.84% since 02/02/24 | -11.62% since 02/02/24 | -6.37% since 02/02/24 | -0.73% since 02/02/24 | +22.96% since 02/02/24 |
| Low | 7.14 on 04/19/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 15.74 on 02/27/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 262.51 on 05/03/24 |
| 6-Month | |||||
| %Chg | +49.58% since 11/03/23 | +2.98% since 11/03/23 | -4.57% since 11/03/23 | +25.14% since 11/03/23 | +16.92% since 11/03/23 |
| Low | 5.03 on 11/10/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 15.74 on 02/27/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 262.51 on 05/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,062,600 | 76,484,144 | 41,997,384 | 13,914,065 | 11,452,196 |
| Shares Outstanding, K | 234,653 | 457,359 | 3,164,837 | 99,507 | 44,366 |
| Annual Sales | 44,580,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -328,070,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 10,890,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -93,000,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 0.85 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 02/27/24 | 1.38 on 05/02/24 | 0.51 on 02/01/24 | 1.20 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.79 | 6.76 | 39.40 | 12.06 |